ALK inhibitors: a new targeted therapy in the treatment of advanced NSCLC.
Casaluce F; Sgambato A; Maione P; Rossi A; Ferrara C; Napolitano A; Palazzolo G; Ciardiello F; Gridelli C; Targeted Oncology, 2013, vol. 8, issue 1, p 55, ISSN 1776260x. ISBN 1776260x.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef